Bill · started in the Commons

Off-patent Drugs Bill

A Bill to require the Secretary of State to seek licences for off-patent drugs in new indications; to require the National Institute for Health and Care Excellence to conduct technology appraisals for off-patent drugs in new indications; and for connected purposes.

In progress Current stage: 2nd reading (Commons)

The story so farThe Off-patent Drugs Bill was introduced in the House of Commons on 24 June 2015 by Nick Thomas-Symonds (Labour). It is now at second reading in the House of Commons. Second reading is the first debate on the overall principle of the bill; if the bill clears it, detailed committee scrutiny follows.

Progress through Parliament

  1. 1st reading Commons 24 Jun 2015
  2. 2nd reading Commons 6 Nov 2015

Source: the official bill page. Last updated 13 May 2016.